Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria.
about
Stage T1N0M0 renal cell carcinoma: the prognosis in Asian patientsMetastatic Renal Cell Carcinoma to Jejunum: An Unusual Case Presentation.Staging of renal cell carcinoma: Current concepts.Active surveillance as the preferred management option for small renal masses.High NUCB2 expression level represents an independent negative prognostic factor in Chinese cohorts of non-metastatic clear cell renal cell carcinoma patientsGene expression profiling of clear cell renal cell carcinoma: gene identification and prognostic classification.Automated grading of renal cell carcinoma using whole slide imagingA pilot study of monoclonal antibody cG250 and low dose subcutaneous IL-2 in patients with advanced renal cell carcinoma.A phase I multiple dose, dose escalation study of cG250 monoclonal antibody in patients with advanced renal cell carcinoma.The contemporary role of surgery in kidney cancerWhole lesion quantitative CT evaluation of renal cell carcinoma: differentiation of clear cell from papillary renal cell carcinoma.Inferior vena cava tumor thrombus after partial nephrectomy for renal cell carcinoma.Predicting survival in patients with metastatic kidney cancer by gene-expression profiling in the primary tumor.Bilateral synchronous adrenal metastases of renal cell carcinoma: A case report and review of the literatureClassification models for clear cell renal carcinoma stage progression, based on tumor RNAseq expression trained supervised machine learning algorithms.miRNA profiling in metastatic renal cell carcinoma reveals a tumour-suppressor effect for miR-215Journal club: Renal masses detected at abdominal CT: radiologists' adherence to guidelines regarding management recommendations and communication of critical resultsCurrent status of targeted therapy for advanced renal cell carcinomaThe utility of screening renal ultrasonography: identifying renal cell carcinoma in an elderly asymptomatic population.Influence of tumor size on oncological outcomes of pathological T3aN0M0 renal cell carcinoma treated by radical nephrectomy.Open surgical management of renal cell carcinoma in the era of minimally invasive kidney surgery.Radiation therapy following targeted therapy in oligometastatic renal cell carcinoma.Order of patient entry influences outcome for metastatic renal cell cancer after non-myeloablative allogeneic stem cell transplantation.Lymphopenia is an independent predictor of inferior outcome in clear cell renal carcinoma.A phase II trial of doxorubicin and gemcitabine in renal cell carcinoma with sarcomatoid features: ECOG 8802Prognostic factors in localized renal cell cancer.Renal cell cancer: radical nephrectomy.Prognostic factors in renal cell cancer.Incidence of synchronous and metachronous adrenal metastases following tumor nephrectomy in renal cell cancer patients: a retrospective bi-center analysis.The impact of histology on clinicopathologic outcomes for patients with renal cell carcinoma and venous tumor thrombus: a matched cohort analysisIs there any potential link among caspase-8, p-p38 MAPK and bcl-2 in clear cell renal cell carcinomas? A comparative immunohistochemical analysis with clinical connotations.From bench to bedside: current and future applications of molecular profiling in renal cell carcinomaRenal cell carcinoma: risk assessment and prognostic factors for newly diagnosed patients.The vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor cediranib (Recentin; AZD2171) inhibits endothelial cell function and growth of human renal tumor xenografts.Low level of PDZ domain containing 1 (PDZK1) predicts poor clinical outcome in patients with clear cell renal cell carcinomaPrognostic factors of overall survival in renal cancer patients - single oncological center study.Adjuvant therapy for high-risk localized kidney cancer- emerging evidence and future clinical trials.Renal Cancer in Recipients of Kidney Transplant.Recurrence pattern in patients with locally advanced renal cell carcinoma: The implications of clinicopathological variables.Extrarenal multiorgan metastases of collecting duct carcinoma of the kidney: a case series.
P2860
Q33579266-D433FB05-28AC-4034-A8C9-6006FB02482EQ33580175-27DEF746-E25D-4CAE-9E95-72AC0E2B5C4AQ33599726-D503F2C2-B3F0-4C2E-9F5E-09849A7E6FDEQ33754041-81EBDACF-15AA-4460-9ABC-A26F58D4420AQ33798805-07C2F099-5243-4ED2-8C5F-D3BB70341A14Q33933694-18D4FB40-6C86-4FAF-976C-CF73FE5D39A0Q34077500-0C5C3A29-74E9-4D54-9EDB-FD62B9862E49Q34111701-A89CD16C-3CAE-4B92-9FF4-73423DF3498CQ34111751-9E6ED6DD-F527-4478-9486-0632FFBC951DQ34983681-E459FD28-5F72-4A2D-AE88-3EB18E3F3ABCQ35074682-7E679DFC-27CC-48D2-AB8D-71F9750B5243Q35134483-F4510B0D-BF58-4749-85DB-47E7316B8CFBQ35162803-D26824B9-B9C8-4090-A4AB-10D5280213D4Q35167639-AD879A4C-A41D-4F27-B30C-64E9F52C875BQ35398065-16FC2EAF-6C5A-4217-B67E-860D3E8EB61EQ35623283-536E5CC3-C0B7-49F0-9590-9D058D7EFA1CQ35637374-CD25F2B4-7EE9-48D3-8E61-02E31EB71350Q35903850-5733AAA4-A27A-4249-88DF-33C9798505AAQ36102293-9058F32F-E786-4F32-A9A3-0833098E3F90Q36306265-1BF4D11A-A087-4BC1-9E04-658668F34647Q36312856-F5A6F7F2-CC04-4CF9-B5A5-A68B7667C8BFQ36336122-1312B6CE-E8BA-4FAE-8557-83094DD3D1A6Q36399856-FB729362-0A7E-4343-9F7A-E581B4569703Q36532950-81233AF1-A381-4244-B093-614B74668FF3Q36593318-CDE1CE7A-FAA8-4176-8306-0056002F3D0FQ36794758-11257FF5-15D4-48F1-A98F-02CA689EDDF7Q36794771-1B99CB9C-36D6-42AE-B1DB-CA869DBBED63Q36794803-82A2AEDF-D760-46C1-962D-1AEC93A05F7CQ36997711-C386C956-0783-4D21-89F7-88369A501B7BQ37010220-A7C9BD9C-1928-4A58-8400-A733CBDDC2ECQ37114091-E9648BAF-397F-4E26-B1BC-E7468FFAA0A3Q37154789-116A3AC9-B5E6-4A39-A6E0-2E0665E66FCEQ37321213-39EEB639-8992-4404-95CC-EABBFDDB38E1Q37458553-DAE5CB69-FE56-4E8F-ACE6-688163DD1076Q37584289-3438FC22-8D2D-47F6-873F-6D1AA28BDC7BQ37682403-F30468C1-B406-42C9-9C73-16F23C81B244Q38686841-2AEBAC59-FF37-4445-9A42-5FCF5EA0B1BAQ39274472-1A1E7DF6-CA4F-40A8-ACC0-0DF963F313F8Q40333846-D0C4D0DB-4C6F-45A5-989C-EE315359ABC5Q40409440-E0B5F109-4249-4092-AD3A-8582132C4CFA
P2860
Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Prognostic indicators for rena ...... sed 1997 TNM staging criteria.
@en
type
label
Prognostic indicators for rena ...... sed 1997 TNM staging criteria.
@en
prefLabel
Prognostic indicators for rena ...... sed 1997 TNM staging criteria.
@en
P2093
P1476
Prognostic indicators for rena ...... sed 1997 TNM staging criteria.
@en
P2093
P304
1090-5; quiz 1295
P356
10.1097/00005392-200004000-00006
P407
P577
2000-04-01T00:00:00Z